Clinical Trial Update: Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nebulized amphotericin B lipid complex for invasive aspergillosis in pediatric patients with acute leukemia has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Invasive Aspergillosis

Drugs mentioned

• Amphotericin B lipid complex (amphotericin B lipid complex)

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Invasive Pulmonary Aspergillosis, Lymphoblastic Leukaemia | Phase 2 | Status: COMPLETED | Results posted: 2015-10-23